Form 3 RayzeBio Inc. For Sep 14 Filed by Wellington Biomedical Innovation Master Investors Cayman II
1. Each share of Series D Preferred Stock is convertible into one share of the Issuer's Common Stock at any time at the holder's election. Upon the closing of the Issuer's initial public offering, all such shares of Series D Preferred Stock will automatically convert into the number of shares of Common Stock of the Issuer shown in column 3. The Series D Preferred Stock has no expiration date.
Comments
Post a Comment